TrialThe New England journal of medicine2022
Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming.
Roos S G Sablerolles et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
75 papers cite itlatest 60 shown
this paperpooled ittrialcites it